(PharmaNewsWire.Com, August 05, 2017 ) According to a latest pipeline review, increase in geriatric population all over the world is a key factor for the rising prevalence of pressure ulcers. In addition to the elderly, people with fragile skin are also at the risk of developing this disease. Once a pressure injury (pressure ulcer) has developed, immediate treatment is required. Considering this fact, analysts have prepared a study covering the descriptive pharmacological action of the therapeutics for pressure ulcers, its complete research and development history, which has been published to the online repository of Market Research Hub (MRH) and titled as “Pressure Ulcers- Pipeline Review, H2 2017”. The report delves into the various facets of the rising prominence of pipeline drugs, therapeutics, and other remedial measures for the pressure ulcers.
In the initial section, this pipeline guide starts by presenting a summary of the pressure ulcers and its therapeutic development. This study provides comprehensive information on the therapeutics under development for Pressure Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Additionally, pipeline products based on several stages of development going from pre-registration till discovery and undisclosed stages are mentioned.
A pressure ulcer, also known as a ‘bed sore’ is caused by continuous pressure on one part of the body. Pressure sores can range from red areas on the surface of the skin to severe tissue damage that goes deep into muscle and bone. If they don’t heal properly, they can lead to problems such as skin infection or bone infection. People most at risk of ulcers are those with a medical condition that limits their ability to change places or those who spend most of their time in a bed or chair. Causes include continuous pressure, friction and shear. Treatment includes antibiotics and nutrition. As per the findings, with comprehensive medical management, many pressure injuries may heal completely without the need for surgical intervention.
Moreover, market size growth projections are also analyzed which gives insights into medical epidemiology trends, new drug variants, and patent expirations, and their impact on its therapeutic market’s growth. In this report, pipeline drugs are analyzed and segmented by development stage, molecule type, and molecular target. By the above major information, pressure ulcers pipeline guide helps buyers in identifying and tracking emerging players in the market and their portfolios enhance policy making capabilities and help to create effective counter-strategies to gain competitive advantage.
Further, pressure ulcers pipeline guide also reviews key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued project. They are EyeGene Inc, NovaLead Pharma Pvt. Ltd., RegeneRx Biopharmaceuticals Inc, RMB-Research GmbH, Izun Pharmaceuticals Corp and MediWound Ltd.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
